Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Dermatology"
DOI: 10.1684/ejd.2020.3717
Abstract: The anti-IgE antibody, omalizumab, is an effective treatment for cutaneous symptoms of chronic spontaneous urticaria (CSU) [1]. As some CSU patients exhibit extracutaneous symptoms (CSU+) [2], we studied the evolution of extracutaneous symptoms in CSU+… read more here.
Keywords: years range; spontaneous urticaria; chronic spontaneous; extracutaneous symptoms ... See more keywords